Acute Pancreatitis II: Clinical Manifestations and Management
Chronic Pancreatitis II: Collaborative Care
Chronic Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Dec 31, 2025

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Zachary Spiritos1, Shakirat Salvador2, Diana Mosquera3
1Department of Medicine, Division of Gastroenterology, Duke University School of Medicine, Durham, NC, USA.
Acute intermittent porphyria (AIP) is a genetic metabolic disorder affecting heme biosynthesis, leading to toxic metabolite buildup. Early diagnosis and management are crucial for this potentially life-threatening hepatic porphyria.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: